Home
/ Windlas Biotech Ipo, Revyu33vmsstqm : What is the price range of windlas biotech limited's ipo?
Windlas Biotech Ipo, Revyu33vmsstqm : What is the price range of windlas biotech limited's ipo?
Windlas Biotech Ipo, Revyu33vmsstqm : What is the price range of windlas biotech limited's ipo?. Earnings per share (eps) = rs 8.70 pe ratio = na. We neither trade nor encourage our readers to trade in the grey market. The company offers a range of cdmo services from product discovery to product development, licensing, and commercial manufacturing. The windlas biotech ipo will hit the market soon, and you can apply for the ipo from 4th august to 6th august 2021. What is the size of the issuance.
What is the listing date of windlas biotech limited ipo? Meanwhile, the price band for the ipo stood at rs 448 to rs 460 per equity share, while the grey market premium. The grey market premium (gmp) for the windlas biotech ipo was listed. The ipo received bids for 1,93,37,310 shares against 61,36,252 shares on offer, as per data with the nse. Windlas biotech grey market premium (gmp) is around ₹ 130 today.
Varydr6xrvd Wm from www.thehindubusinessline.com The ipo received bids for 73,89,420 shares against 61,36,252. The bidding will close on august 6. The price range for the limited ipo of windlas biotech is rs. Who is the registrar for windlas biotech ipo ? What is the size of the issuance. The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. Windlas biotech limited ipo will list on 17 aug 2021. The company to raise ₹165 crores via fresh issue and the offer for sale will be 5,142,067 shares as per drhp, the face value of the windlas biotech share is ₹5.
We share the gmp information for educational purposes only, so that, you can make an informed decision.
The ipo received bids for 1,93,37,310 shares against 61,36,252 shares on offer, as per data with the nse. What is the price band for windlas biotech ipo ? The company offers a range of cdmo services from product discovery to product development, licensing, and commercial manufacturing. The grey market is an unofficial platform, wherein trading starts after the announcement of ipo price band till the listing of. What is the lot size for windlas biotech limited's ipo? Is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organisations segment in india. Siddharth a july 29, 2021. However, the head office shifted to uttarakhand in 2009 under shareholders approval. The registrar is link intime india private limited. Return on net worth (ronw) = 18.19% net asset value =109.36 per share. Windlas biotech limited, a leading manufacturer in pharmaceutical designs, launched its initial public offering (ipo) today (4 august). Retail investors can subscribe to the ipo, the minimum lot size is 30 shares, up to a maximum of 14 lots i.e. We neither trade nor encourage our readers to trade in the grey market.
The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. The company to raise ₹165 crores via fresh issue and the offer for sale will be 5,142,067 shares as per drhp, the face value of the windlas biotech share is ₹5. May 15, 2021 by profitmust. The registrar is link intime india private limited.
Am2snn5m7spcm from images.financialexpress.com Grey market premium (gmp) today: Windlas biotech's ipo was subscribed 1.20 times, with the retail individual investors category receiving 2.36 times subscription. The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. The company plans to raise rs 401.53 crore with the help of fresh issuance of equity. Windlas biotech ipo opens on august 4 and closes on august 6.; Windlas biotech is planning to raise ₹401.54 crores through an ipo which consists of a fresh issue of ₹165 crores worth equity and ofs (offer for sale) of ₹236.54 by existing shareholders. The bidding will close on august 6. Incorporated in 2001, windlas biotech ltd.
Windlas biotech ipo, which opens today, comprises a fresh issue of shares worth rs 165 crore and an offer for sale of shares worth rs 236.5 crore (51,42,067 equity shares) by existing selling shareholders.
Windlas biotech ipo is an ipo of windlas biotech limited which is one of the top 5 companies in pharmaceutical formulation contract development and manufacturing organization (cdmo) segment in india. Windlas biotech is planning to raise ₹401.54 crores through an ipo which consists of a fresh issue of ₹165 crores worth equity and ofs (offer for sale) of ₹236.54 by existing shareholders. Windlas biotech ipo will hit the market in 2021. Windlas biotech ipo subscription details as on 4 august 2021 till 11:00 am Windlas biotech limited ipo will list on 17 aug 2021. The grey market premium (gmp) for the windlas biotech ipo was listed. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. Is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organisations segment in india. The ipo received bids for 73,89,420 shares against 61,36,252. The issue is priced at ₹448 to ₹460 per equity share. Windlas biotech is coming up with ipo that would open for subscription on 4th august 2021. Analysts at marwadi shares, angel broking, gepl capital and bp wealth also suggest subscribing to the issue. The offer will be available till friday, august 6, 2021.
The initial public offer of equity shares comprising a fresh issue of up to rs.401 crore. Windlas biotech limited ipo will list on 17 aug 2021. What is the price band for windlas biotech ipo ? The ipo received bids for 1,93,37,310 shares against 61,36,252 shares on offer, as per data with the nse. The windlas biotech ipo lot size is 30 shares and the minimum order quantity is 30 shares.
Ul C5dcpuo4hfm from www.valueresearchonline.com Face value = rs 5. What is the price range of windlas biotech limited's ipo? Windlas biotech ipo is an ipo of windlas biotech limited which is one of the top 5 companies in pharmaceutical formulation contract development and manufacturing organization (cdmo) segment in india. Is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organisations segment in india. Windlas biotech limited is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (cdmo) industry in india in terms of revenue. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. The ipo received bids for 73,89,420 shares against 61,36,252. May 15, 2021 by profitmust.
What is the lot size for windlas biotech limited's ipo?
10 key things to know before the issue opens windlas biotech is amongst the top five players in the domestic pharmaceutical formulations cdmos in terms of revenue, with focus. The price range for the limited ipo of windlas biotech is rs. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. The ipo opens on aug 4, 2021, and closes on aug 6, 2021. Windlas biotech limited, a leading manufacturer in pharmaceutical designs, launched its initial public offering (ipo) today (4 august). Windlas biotech is coming up with ipo that would open for subscription on 4th august 2021. Demat account, trading application and upi id are mandatory if you are applying for an initial public offering (ipo). Siddharth a july 29, 2021. What is the lot size for windlas biotech limited's ipo? Windlas biotech limited ipo will list on 17 aug 2021. Windlas biotech, an indian drugmaker, is set to open for initial public offering on august 4, with a fresh issue of rs 165 crore and an offer for sale of 51.42 lakh equity shares by existing shareholders. Link intime india private ltd is the registrar for the ipo. The offer will be available till friday, august 6, 2021.
